{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:08:22Z","timestamp":1788815302885,"version":"build-2803163510"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IFA17-LSPA82"],"award-info":[{"award-number":["IFA17-LSPA82"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.lfs.2022.121261","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:06:31Z","timestamp":1670357191000},"page":"121261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers"],"prefix":"10.1016","volume":"313","author":[{"given":"Prankur","family":"Awasthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-9039","authenticated-orcid":false,"given":"Saba","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2022.121261_bb0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","article-title":"The landscape of viral associations in human cancers","volume":"52","author":"Zapatka","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.lfs.2022.121261_bb0010","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr Virus and Kaposi\u2019s Sarcoma Herpesvirus\/Human Herpesvirus 8. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 70. Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK385507."},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.7150\/thno.29622","article-title":"Genome-wide profiling of epstein-barr virus integration by targeted sequencing in epstein-barr virus associated malignancies","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2022.121261_bb0020","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fonc.2019.00713","article-title":"The global landscape of EBV-associated tumors","volume":"9","author":"Shannon-Lowe","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2022.121261_bb0025","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2022.121261_bb0030","first-page":"17","article-title":"Tumor associations of EBV-historical perspectives","volume":"390","author":"Klein","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.lfs.2022.121261_bb0035","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/v13050877","article-title":"Pathogenic role of Epstein\u2014Barr virus in lung cancers","volume":"13","author":"Becnel","year":"2021","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1093\/gbe\/evu054","article-title":"Genome-wide analysis of wild-type epstein-barr virus genomes derived from healthy individuals of the 1,000 genomes project","volume":"6","author":"Santpere","year":"2014","journal-title":"Genome Biol. Evol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--part b: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet. Oncology"},{"key":"10.1016\/j.lfs.2022.121261_bb0055","author":"B\u00f6hm"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/cancers11020217","article-title":"The phylogeographic diversity of EBV and admixed ancestry in the americas-another model of disrupted human-pathogen co-evolution","volume":"11","author":"Corval\u00e1n","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12935-021-01793-3","article-title":"Signaling pathways of EBV-induced oncogenesis","volume":"21","author":"Luo","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0070","doi-asserted-by":"crossref","first-page":"9908","DOI":"10.1128\/JVI.73.12.9908-9916.1999","article-title":"The residues between the two transformation effector sites of epstein-barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation","volume":"73","author":"Izumi","year":"1999","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0075","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1073\/pnas.94.4.1447","article-title":"The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.lfs.2022.121261_bb0080","doi-asserted-by":"crossref","first-page":"12592","DOI":"10.1073\/pnas.94.23.12592","article-title":"The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB","volume":"94","author":"Izumi","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","article-title":"The epstein-barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family","volume":"80","author":"Mosialos","year":"1995","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0090","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1128\/jvi.69.2.675-683.1995","article-title":"The epstein-barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues","volume":"69","author":"Kaye","year":"1995","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0095","first-page":"461","article-title":"Transformation of balb 3T3 cells by the BNLF-1 gene of epstein-barr virus","volume":"2","author":"Baichwal","year":"1988","journal-title":"Oncogene"},{"issue":"19","key":"10.1016\/j.lfs.2022.121261_bb0100","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.lfs.2022.121261_bb0105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"3 Pt 2","key":"10.1016\/j.lfs.2022.121261_bb0110","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","article-title":"An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells","volume":"43","author":"Wang","year":"1985","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.lfs.2022.121261_bb0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.cr.7290347","article-title":"Regulation of survivin and CDK4 by epstein-barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines","volume":"15","author":"Ai","year":"2005","journal-title":"Cell Res."},{"issue":"17","key":"10.1016\/j.lfs.2022.121261_bb0120","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1158\/0008-5472.CAN-08-1178","article-title":"EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration","volume":"68","author":"Shair","year":"2008","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0125","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1128\/JVI.01888-07","article-title":"Epstein-barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway","volume":"82","author":"Dawson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2022.121261_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1476-4598-9-155","article-title":"Upregulation of Id1 by epstein-barr virus-encoded LMP1 confers resistance to TGFbeta-mediated growth inhibition","volume":"9","author":"Lo","year":"2010","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0135","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1128\/jvi.70.12.8653-8659.1996","article-title":"Epstein-barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene","volume":"70","author":"Fries","year":"1996","journal-title":"J. Virol."},{"issue":"24","key":"10.1016\/j.lfs.2022.121261_bb0140","doi-asserted-by":"crossref","first-page":"13470","DOI":"10.1128\/JVI.78.24.13470-13478.2004","article-title":"Induction of Id1 and Id3 by latent membrane protein 1 of epstein-barr virus and regulation of p27\/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation","volume":"78","author":"Everly","year":"2004","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.lfs.2022.121261_bb0145","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","article-title":"Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation","volume":"86","author":"Cohen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0150","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/JVI.01637-08","article-title":"Nuclear factor-kappaB binds to the epstein-barr virus LMP1 promoter and upregulates its expression","volume":"83","author":"Johansson","year":"2009","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0155","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","article-title":"The proto-oncogene c-myc is a direct target gene of epstein-barr virus nuclear antigen 2","volume":"73","author":"Kaiser","year":"1999","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0160","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/jvi.64.7.3407-3416.1990","article-title":"Epstein-barr virus nuclear antigen 2 transactivates latent membrane protein LMP1","volume":"64","author":"Wang","year":"1990","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semcancer.2012.01.004","article-title":"The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)","volume":"22","author":"Dawson","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2022.121261_bb0170","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2015.13","article-title":"Novel roles and therapeutic targets of epstein-barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma","volume":"17","author":"Tao","year":"2015","journal-title":"Expert Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcancer.2011.12.011","article-title":"Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches","volume":"22","author":"Lo","year":"2012","journal-title":"Semin. Cancer Biol."},{"issue":"10","key":"10.1016\/j.lfs.2022.121261_bb0180","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc3138","article-title":"Cancer research: past, present and future","volume":"11","author":"Cao","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41698-017-0018-x","article-title":"EBV based cancer prevention and therapy in nasopharyngeal carcinoma","volume":"1","author":"Cao","year":"2017","journal-title":"NPJ Precis. Oncol."},{"issue":"24","key":"10.1016\/j.lfs.2022.121261_bb0190","doi-asserted-by":"crossref","first-page":"11668","DOI":"10.1158\/0008-5472.CAN-06-2194","article-title":"Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun NH (2)-terminal kinase signaling","volume":"66","author":"Tsai","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0195","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41419-018-0662-2","article-title":"DNMT1 mediates metabolic reprogramming induced by epstein-barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma","volume":"9","author":"Luo","year":"2018","journal-title":"Cell Death Dis."},{"issue":"49","key":"10.1016\/j.lfs.2022.121261_bb0200","doi-asserted-by":"crossref","first-page":"81512","DOI":"10.18632\/oncotarget.13130","article-title":"TET2 functions as a resistance factor against DNA methylation acquisition during epstein-barr virus infection","volume":"7","author":"Namba-Fukuyo","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.lfs.2022.121261_bb0205","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00018-017-2721-8","article-title":"The TET enzymes","volume":"75","author":"Koivunen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.lfs.2022.121261_bb0210","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.7150\/thno.30941","article-title":"EBV(LMP1)-induced metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter","volume":"9","author":"Shi","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2022.121261_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.02.009","article-title":"Wild-type IDH2 contributes to epstein-barr virus-dependent metabolic alterations and tumorigenesis","volume":"36","author":"Shi","year":"2020","journal-title":"Mol. Metab."},{"issue":"9","key":"10.1016\/j.lfs.2022.121261_bb0220","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.celrep.2017.05.012","article-title":"2-HG inhibits necroptosis by stimulating DNMT1-dependent hypermethylation of the RIP3 promoter","volume":"19","author":"Yang","year":"2017","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/1568026615666150825141505","article-title":"DNA methyltransferases inhibitors from natural sources","volume":"16","author":"Zwergel","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"42","key":"10.1016\/j.lfs.2022.121261_bb0230","doi-asserted-by":"crossref","first-page":"68708","DOI":"10.18632\/oncotarget.11929","article-title":"Grifolin inhibits tumor cells adhesion and migration via suppressing interplay between PGC1\u03b1 and Fra-1\/LSF-MMP2\/CD44 axes","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"issue":"40","key":"10.1016\/j.lfs.2022.121261_bb0235","doi-asserted-by":"crossref","first-page":"42704","DOI":"10.18632\/oncotarget.5678","article-title":"Grifolin directly targets ERK1\/2 to epigenetically suppress cancer cell metastasis","volume":"6","author":"Luo","year":"2015","journal-title":"Oncotarget"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2022.121261_bb0240","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejphar.2011.08.026","article-title":"DAPK1 mediates the G1 phase arrest in human nasopharyngeal carcinoma cells induced by grifolin, a potential antitumor natural product","volume":"670","author":"Luo","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0245","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejca.2010.09.021","article-title":"Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells","volume":"47","author":"Luo","year":"2011","journal-title":"Eur. J. Cancer (Oxford, England: 1990)"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2007.09.001","article-title":"Grifolin, a potential antitumor natural product from the mushroom albatrellus confluens, induces cell-cycle arrest in G1 phase via the ERK1\/2 pathway","volume":"258","author":"Ye","year":"2007","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0255","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s10495-007-0062-z","article-title":"Grifolin induces apoptosis via inhibition of PI3K\/AKT signalling pathway in human osteosarcoma cells","volume":"12","author":"Jin","year":"2007","journal-title":"Apoptosis"},{"issue":"16","key":"10.1016\/j.lfs.2022.121261_bb0260","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1016\/j.febslet.2005.05.013","article-title":"Grifolin, a potential antitumor natural product from the mushroom albatrellus confluens, inhibits tumor cell growth by inducing apoptosis in vitro","volume":"579","author":"Ye","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2022.121261_bb0265","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-981-10-5765-6_6","article-title":"EBV infection and glucose metabolism in nasopharyngeal carcinoma","volume":"1018","author":"Zhang","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"37","key":"10.1016\/j.lfs.2022.121261_bb0270","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1038\/onc.2014.32","article-title":"Targeting epstein-barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy","volume":"33","author":"Xiao","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2016.05.032","article-title":"EBV-LMP1 suppresses the DNA damage response through DNA-PK\/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma","volume":"380","author":"Lu","year":"2016","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0280","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cmet.2019.06.003","article-title":"Epstein-barr-virus-induced one-carbon metabolism drives B cell transformation","volume":"30","author":"Wang","year":"2019","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0285","doi-asserted-by":"crossref","first-page":"E782","DOI":"10.1073\/pnas.1517141113","article-title":"Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization","volume":"113","author":"McFadden","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0290","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.1919133117","article-title":"A promiscuous inflammasome sparks replication of a common tumor virus","volume":"117","author":"Burton","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0295","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.celrep.2017.04.062","article-title":"A temporal proteomic map of epstein-barr virus lytic replication in B cells","volume":"19","author":"Ersing","year":"2017","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1615\/CritRevImmunol.2014010041","article-title":"Latent membrane protein 1 and the B lymphocyte-a complex relationship","volume":"34","author":"Stunz","year":"2014","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.lfs.2022.121261_bb0305","first-page":"119","article-title":"The latent membrane protein 1 (LMP1)","volume":"391","author":"Kieser","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"23","key":"10.1016\/j.lfs.2022.121261_bb0310","doi-asserted-by":"crossref","first-page":"7291","DOI":"10.1158\/0008-5472.CAN-11-1715","article-title":"IKK\u03b2 and NF-\u03baB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1","volume":"71","author":"Sommermann","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2022.121261_bb0315","series-title":"Fields Virology","author":"Howley","year":"2021"},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0320","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.1128\/MCB.24.12.5223-5234.2004","article-title":"Epstein-barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha","volume":"24","author":"Wakisaka","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"24","key":"10.1016\/j.lfs.2022.121261_bb0325","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1038\/s41388-019-0749-y","article-title":"mTORC2-mediated PDHE1\u03b1 nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma","volume":"38","author":"Zhang","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0330","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.yexcr.2017.08.005","article-title":"Enhanced aerobic glycolysis of nasopharyngeal carcinoma cells by epstein-barr virus latent membrane protein 1","volume":"359","author":"Sung","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0335","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02168-16","article-title":") Epstein-Barr virus-encoded latent membrane protein 1 upregulates glucose transporter 1 transcription via the mTORC1\/NF-\u03baB signaling pathways","volume":"91","author":"Zhang","year":"2017","journal-title":"J. Virology"},{"issue":"11","key":"10.1016\/j.lfs.2022.121261_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007394","article-title":"Poly (ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1","volume":"14","author":"Hulse","year":"2018","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042072","article-title":"Epstein-barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect","volume":"7","author":"Darekar","year":"2012","journal-title":"PLoS One"},{"issue":"25","key":"10.1016\/j.lfs.2022.121261_bb0350","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022495118","article-title":"Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas","volume":"118","author":"Bonglack","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.121261_bb0355","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2020.03.004","article-title":"Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling","volume":"478","author":"Wu","year":"2020","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0360","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.4575","article-title":"Activation of the FGFR1 signalling pathway by the epstein-barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells","volume":"237","author":"Lo","year":"2015","journal-title":"J. Pathol."},{"issue":"24","key":"10.1016\/j.lfs.2022.121261_bb0365","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1038\/s41388-019-0749-y","article-title":"mTORC2-mediated PDHE1\u03b1 nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma","volume":"38","author":"Zhang","year":"2019","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01857-20","article-title":"Epstein-Barr virus-encoded latent membrane protein 1 and B-cell growth transformation induce lipogenesis through fatty acid synthase","volume":"95","author":"Hulse","year":"2021","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0375","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/path.5130","article-title":"Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the epstein-barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma","volume":"246","author":"Lo","year":"2018","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0380","first-page":"560","article-title":"Metabolic control by DNA tumor virus-encoded proteins","volume":"10","author":"Prusinkiewicz","year":"2021","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0385","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/v12121377","article-title":"The crosstalk of epigenetics and metabolism in herpesvirus infection","volume":"12","author":"Pei","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0390","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12915-019-0678-9","article-title":"Viral hijacking of cellular metabolism","volume":"17","author":"Thaker","year":"2019","journal-title":"BMC Biol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0395","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02168-16","article-title":"Epstein-Barr virus-encoded latent membrane protein 1 upregulates glucose transporter 1 transcription via the mTORC1\/NF-\u03baB signaling pathways","volume":"91","author":"Zhang","year":"2017","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006503","article-title":"LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma","volume":"13","author":"Cai","year":"2017","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0405","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cmet.2019.06.003","article-title":"Epstein-barr-virus-induced one-carbon metabolism drives B cell transformation","volume":"30","author":"Wang","year":"2019","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.lfs.2022.121261_bb0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134896","article-title":"LMP1 increases expression of NADPH oxidase (NOX) and its regulatory subunit p22 in NP69 nasopharyngeal cells and makes them sensitive to a treatment by a NOX inhibitor","volume":"10","author":"Sun","year":"2015","journal-title":"PloS one"},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0415","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.4161\/cbt.3.12.1243","article-title":"High frequency of common deletion (4981 bp) in mitochondrial DNA in nasopharyngeal carcinoma and its correlation with patient age and clinical stages","volume":"3","author":"Shao","year":"2004","journal-title":"Cancer Biol. Ther."},{"issue":"1732","key":"10.1016\/j.lfs.2022.121261_bb0420","first-page":"20160270","article-title":"Epstein-barr virus infection and nasopharyngeal carcinoma","volume":"372","author":"Tsao","year":"2017","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.lfs.2022.121261_bb0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13027-020-00295-7","article-title":"Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers","volume":"15","author":"Tavakolian","year":"2020","journal-title":"Infect. Agents Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0430","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41392-020-0151-9","article-title":"Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0435","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/carcin\/bgu069","article-title":"Epstein-barr virus latent membrane protein-2A alters mitochondrial dynamics promoting cellular migration mediated by notch signaling pathway","volume":"35","author":"Pal","year":"2014","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0440","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12929-019-0569-y","article-title":"Ubiquitin-mediated regulation of autophagy","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2022.121261_bb0445","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcell.2018.00128","article-title":"Crosstalk between mammalian autophagy and the ubiquitin-proteasome system","volume":"6","author":"Kocaturk","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2022.121261_bb0450","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.virol.2013.10.018","article-title":"KSHV LANA and EBV LMP1 induce the expression of UCH-L1 following viral transformation","volume":"448","author":"Bentz","year":"2014","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0455","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4161\/cc.20771","article-title":"Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53","volume":"11","author":"Li","year":"2012","journal-title":"Cell Cycle (Georgetown, Tex.)"},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0460","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1128\/JVI.01358-08","article-title":"The unfolded protein response and autophagy: herpesviruses rule!","volume":"83","author":"Lee","year":"2009","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0465","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood-2007-07-100032","article-title":"The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis","volume":"111","author":"Lee","year":"2008","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.lfs.2022.121261_bb0470","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1038\/sj.onc.1210946","article-title":"The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy","volume":"27","author":"Lee","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0475","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/cells1030617","article-title":"How human tumor viruses make use of autophagy","volume":"1","author":"Pratt","year":"2012","journal-title":"Cells"},{"key":"10.1016\/j.lfs.2022.121261_bb0480","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fimmu.2012.00170","article-title":"Autophagy and immunity - insights from human herpesviruses","volume":"3","author":"Williams","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2022.121261_bb0485","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fgene.2016.00204","article-title":"DNA damage response and autophagy: a meaningful partnership","volume":"7","author":"Eliopoulos","year":"2016","journal-title":"Front. Genet."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0490","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02251-16","article-title":"CD63 regulates Epstein-Barr virus LMP1 exosomal packaging, enhancement of vesicle production, and noncanonical NF-\u03baB signaling","volume":"91","author":"Hurwitz","year":"2017","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0495","doi-asserted-by":"crossref","first-page":"6282","DOI":"10.18632\/oncotarget.23676","article-title":"LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death","volume":"9","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007541","article-title":"p62-mediated selective autophagy endows virus-transformed cells with insusceptibility to DNA damage under oxidative stress","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.lfs.2022.121261_bb0505","article-title":"Algorithm-based meta-analysis reveals the mechanistic interaction of the tumor suppressor LIMD1 with non-small-cell lung carcinoma","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"33","key":"10.1016\/j.lfs.2022.121261_bb0510","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0515","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.molcel.2011.07.039","article-title":"Serine 403 phosphorylation of p62\/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins","volume":"44","author":"Matsumoto","year":"2011","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004987","article-title":"Proteotoxic stress induces phosphorylation of p62\/SQSTM1 by ULK1 to regulate selective autophagic clearance of protein aggregates","volume":"11","author":"Lim","year":"2015","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0525","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/cr.2017.40","article-title":"Ubiquitylation of p62\/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress","volume":"27","author":"Peng","year":"2017","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0530","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrm.2016.58","article-title":"Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers","volume":"17","author":"Schwertman","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0535","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.trecan.2017.03.002","article-title":"Necroptosis and cancer","volume":"3","author":"Najafov","year":"2017","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0540","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41419-017-0081-9","article-title":"Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1\/3 ubiquitination","volume":"9","author":"Liu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0545","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/MCB.19.3.1651","article-title":"Epstein-Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma","volume":"19","author":"Ruf","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0550","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/BF02256110","article-title":"Epstein-Barr virus latent membrane protein 1: structure and functions","volume":"10","author":"Li","year":"2003","journal-title":"J. Biomed. Sci."},{"issue":"18","key":"10.1016\/j.lfs.2022.121261_bb0555","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1038\/sj.onc.1202144","article-title":"Epstein-barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions","volume":"17","author":"Floettmann","year":"1998","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0560","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/scbi.2001.0410","article-title":"LMP1 structure and signal transduction","volume":"11","author":"Eliopoulos","year":"2001","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0565","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/ijms21041501","article-title":"Extranodal NK\/T-cell lymphomas: the role of natural killer cells and EBV in lymphomagenesis","volume":"21","author":"Saleem","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0570","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/his.13857","article-title":"Clinicopathological evaluation of the programmed cell death 1 (PD1)\/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome","volume":"75","author":"Veloza","year":"2019","journal-title":"Histopathology"},{"issue":"9","key":"10.1016\/j.lfs.2022.121261_bb0575","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136476","article-title":"PD-1 blockade can restore functions of T-cells in epstein-barr virus-positive diffuse large B-cell lymphoma in vitro","volume":"10","author":"Quan","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0580","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.4049\/jimmunol.1801420","article-title":"EBV latency III-transformed B cells are inducers of conventional and unconventional regulatory T cells in a PD-L1-dependent manner","volume":"203","author":"Auclair","year":"2019","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0585","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/cei.12682","article-title":"Epstein-barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired","volume":"182","author":"C\u00e1rdenas","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0590","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/ejh.13274","article-title":"The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma","volume":"103","author":"Keane","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.lfs.2022.121261_bb0595","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.semcancer.2015.04.006","article-title":"Cross-talk between epstein-barr virus and microenvironment in the pathogenesis of lymphomas","volume":"34","author":"Dolcetti","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0600","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1349-7006.2011.01924.x","article-title":"Cytokine signatures of transformed B cells with distinct epstein-barr virus latencies as a potential diagnostic tool for B cell lymphoma","volume":"102","author":"Miyauchi","year":"2011","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.lfs.2022.121261_bb0605","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1111\/j.1600-6143.2009.02781.x","article-title":"Activation of the JAK\/STAT pathway in epstein barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma","volume":"9","author":"Vaysberg","year":"2009","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"Pt 5","key":"10.1016\/j.lfs.2022.121261_bb0610","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1099\/vir.0.049221-0","article-title":"Epstein-barr virus LMP2A increases IL-10 production in mitogen-stimulated primary B-cells and B-cell lymphomas","volume":"94","author":"Incrocci","year":"2013","journal-title":"J. Gen. Virol."},{"issue":"Pt 4","key":"10.1016\/j.lfs.2022.121261_bb0615","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1099\/vir.0.18845-0","article-title":"A novel function for the epstein-barr virus transcription factor EB1\/Zta: induction of transcription of the hIL-10 gene","volume":"84","author":"Mahot","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0620","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical hodgkin lymphoma","volume":"99","author":"Skinnider","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2022.121261_bb0625","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0065-230X(10)07004-1","article-title":"Role of EBERs in the pathogenesis of EBV infection","volume":"107","author":"Iwakiri","year":"2010","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0630","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hon.2465","article-title":"Epstein-barr virus lytic cycle involvement in diffuse large B cell lymphoma","volume":"36","author":"Cohen","year":"2018","journal-title":"Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0635","doi-asserted-by":"crossref","first-page":"10813","DOI":"10.1038\/s41598-017-11052-z","article-title":"Cytotoxic response against epstein barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact","volume":"7","author":"Cohen","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0640","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1038\/s41379-020-0616-y","article-title":"Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers","volume":"33","author":"El Hussein","year":"2020","journal-title":"Mod. Pathol."},{"issue":"11","key":"10.1016\/j.lfs.2022.121261_bb0645","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/biology9110390","article-title":"Lymphotropic viruses: chronic inflammation and induction of cancers","volume":"9","author":"Harhaj","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.lfs.2022.121261_bb0650","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.640207","article-title":"The role of EBV-encoded LMP1 in the NPC tumor microenvironment: from function to therapy","volume":"11","author":"Lo","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0655","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/cas.13473","article-title":"Modulation of the tumor microenvironment by epstein-barr virus latent membrane protein 1 in nasopharyngeal carcinoma","volume":"109","author":"Yoshizaki","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2022.121261_bb0660","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fimmu.2015.00019","article-title":"Turning 21: induction of miR-21 as a key switch in the inflammatory response","volume":"6","author":"Sheedy","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0665","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jir.2018.0155","article-title":"MicroRNA-155: a master regulator of inflammation","volume":"39","author":"Mahesh","year":"2019","journal-title":"J. Interf. Cytokine Res."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0670","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/rmv.1850","article-title":"MicroRNA regulation of viral immunity, latency, and carcinogenesis of selected tumor viruses and HIV","volume":"25","author":"Wang","year":"2015","journal-title":"Rev. Med. Virol."},{"issue":"16","key":"10.1016\/j.lfs.2022.121261_bb0675","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1128\/JVI.00570-11","article-title":"Oncogenic IRFs provide a survival advantage for epstein-barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression","volume":"85","author":"Wang","year":"2011","journal-title":"J. Virol."},{"issue":"16","key":"10.1016\/j.lfs.2022.121261_bb0680","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/onc.2016.380","article-title":"LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and src is required","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006503","article-title":"LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma","volume":"13","author":"Cai","year":"2017","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","article-title":"Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies","volume":"113","author":"Akers","year":"2013","journal-title":"J. Neuro-Oncol."},{"issue":"10","key":"10.1016\/j.lfs.2022.121261_bb0695","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1128\/JVI.02470-14","article-title":"Exosomal communication goes viral","volume":"89","author":"Meckes","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0700","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccell.2014.09.005","article-title":"Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis","volume":"26","author":"Melo","year":"2014","journal-title":"Cancer cell"},{"issue":"6216","key":"10.1016\/j.lfs.2022.121261_bb0705","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1126\/science.aaa4024","article-title":"Cancer. Malicious exosomes","volume":"346","author":"Anastasiadou","year":"2014","journal-title":"Science (New York, N.Y.)"},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0710","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02251-16","article-title":"CD63 regulates Epstein-Barr virus LMP1 exosomal packaging, enhancement of vesicle production, and noncanonical NF-\u03baB signaling","volume":"91","author":"Hurwitz","year":"2017","journal-title":"J. Virol."},{"issue":"47","key":"10.1016\/j.lfs.2022.121261_bb0715","doi-asserted-by":"crossref","first-page":"20370","DOI":"10.1073\/pnas.1014194107","article-title":"Human tumor virus utilizes exosomes for intercellular communication","volume":"107","author":"Meckes","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0720","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1073\/pnas.2237224100","article-title":"Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling","volume":"101","author":"Yasui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.lfs.2022.121261_bb0725","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1073\/pnas.081075298","article-title":"Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors","volume":"98","author":"Higuchi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0730","first-page":"2299","article-title":"An epstein-barr virus transforming protein associates with vimentin in lymphocytes","volume":"7","author":"Liebowitz","year":"1987","journal-title":"Mol. Cell. Biol."},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0735","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1093\/emboj\/cdg284","article-title":"LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments","volume":"22","author":"Lam","year":"2003","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0740","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1128\/JVI.02519-12","article-title":"Epstein-barr virus LMP1 modulates lipid raft microdomains and the vimentin cytoskeleton for signal transduction and transformation","volume":"87","author":"Meckes","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2022.121261_bb0745","doi-asserted-by":"crossref","first-page":"26334","DOI":"10.3402\/jev.v4.26334","article-title":"Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes","volume":"4","author":"Verweij","year":"2015","journal-title":"J. Extracell. Vesicles"},{"issue":"47","key":"10.1016\/j.lfs.2022.121261_bb0750","doi-asserted-by":"crossref","first-page":"20370","DOI":"10.1073\/pnas.1014194107","article-title":"Human tumor virus utilizes exosomes for intercellular communication","volume":"107","author":"Meckes","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2022.121261_bb0755","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1038\/emboj.2011.123","article-title":"LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-[kappa]B activation","volume":"30","author":"Verweij","year":"2011","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0760","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00030-18","article-title":"C-terminal farnesylation of UCH-L1 plays a role in transport of Epstein-Barr virus primary oncoprotein LMP1 to exosomes","volume":"3","author":"Kobayashi","year":"2018","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0765","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00428-019-02605-w","article-title":"Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic hodgkin lymphoma","volume":"475","author":"Uccini","year":"2019","journal-title":"Virchows Archiv Int. J. Pathol."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0770","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00589-20","article-title":"Epstein-Barr virus LMP1 promotes syntenin-1- and Hrs-induced extracellular vesicle formation for its own secretion to increase cell proliferation and migration","volume":"11","author":"Nkosi","year":"2020","journal-title":"MBio"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0775","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/aps.2018.17","article-title":"Tumor exosomes: a double-edged sword in cancer therapy","volume":"39","author":"Sun","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0780","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.vaccine.2007.11.019","article-title":"Generation and characterization of a preventive and therapeutic HPV DNA vaccine","volume":"26","author":"Kim","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0785","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jnci\/56.4.697","article-title":"Epstein-barr virus\u2013is it time to develop a vaccine program?","volume":"56","author":"Epstein","year":"1976","journal-title":"J. Natl. Cancer Inst."},{"issue":"6043","key":"10.1016\/j.lfs.2022.121261_bb0790","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/318287a0","article-title":"Protection of cottontop tamarins against epstein-barr virus-induced malignant lymphoma by a prototype subunit vaccine","volume":"318","author":"Epstein","year":"1985","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0795","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.lfs.2022.121261_bb0800","doi-asserted-by":"crossref","first-page":"B194","DOI":"10.1016\/j.vaccine.2012.09.041","article-title":"The need and challenges for development of an epstein-barr virus vaccine","volume":"31","author":"Cohen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.lfs.2022.121261_bb0805","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2014.02.005","article-title":"Progress, prospects, and problems in epstein-barr virus vaccine development","volume":"6","author":"Balfour","year":"2014","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0810","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2014.27","article-title":"Epstein-barr virus vaccines","volume":"4","author":"Cohen","year":"2015","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.lfs.2022.121261_bb0815","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2015.13","article-title":"Novel roles and therapeutic targets of epstein-barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma","volume":"17","author":"Tao","year":"2015","journal-title":"Expert Rev. Mol. Med."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0820","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12885-016-3027-1","article-title":"Therapeutic vaccine targeting epstein-barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo","volume":"17","author":"Lin","year":"2017","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0825","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1535-7163.MCT-11-0725","article-title":"A human fab-based immunoconjugate specific for the LMP1 extracellular domain inhibits nasopharyngeal carcinoma growth in vitro and in vivo","volume":"11","author":"Chen","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0830","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/ijms13022208","article-title":"A novel LMP1 antibody synergizes with mitomycin C to inhibit nasopharyngeal carcinoma growth in vivo through inducing apoptosis and downregulating vascular endothelial growth factor","volume":"13","author":"Mao","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0835","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/v5041131","article-title":"Generation and characterization of a novel recombinant antibody against LMP1-TES1 of epstein-barr virus isolated by phage display","volume":"5","author":"Zhang","year":"2013","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0840","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3892\/ol.2013.1219","article-title":"Characterization of human fab antibody fragments specific to LMP1 (HLEAFab) in nasopharyngeal carcinoma for potential molecular diagnosis and therapeutic applications","volume":"5","author":"Zhang","year":"2013","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb0845","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.18632\/oncotarget.14032","article-title":"A neutralized human LMP1-IgG inhibits ENKTL growth by suppressing the JAK3\/STAT3 signaling pathway","volume":"8","author":"Mao","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0850","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.fct.2012.02.034","article-title":"The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-\u03baB activation and the viability of EBV-transformed lymphoblastoid cell lines","volume":"50","author":"Kim","year":"2012","journal-title":"Food Chem. Toxicol."},{"issue":"11","key":"10.1016\/j.lfs.2022.121261_bb0855","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082688","article-title":"Lupeol is one of active components in the extract of Chrysanthemum indicum linne that inhibits LMP1-induced NF-\u03baB activation","volume":"8","author":"Kang","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0860","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2013.06.012","article-title":"Piperlongumine inhibits LMP1\/MYC-dependent mouse B-lymphoma cells","volume":"436","author":"Han","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2022.121261_bb0865","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bbrc.2014.12.023","article-title":"Triptolide inhibits proliferation of epstein-barr virus-positive B lymphocytes by down-regulating expression of a viral protein LMP1","volume":"456","author":"Zhou","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0870","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3892\/mmr.2013.1836","article-title":"Fisetin inhibits migration, invasion and epithelial-mesenchymal transition of LMP1-positive nasopharyngeal carcinoma cells","volume":"9","author":"Li","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"22","key":"10.1016\/j.lfs.2022.121261_bb0875","doi-asserted-by":"crossref","first-page":"9835","DOI":"10.7314\/APJCP.2014.15.22.9835","article-title":"Interference of fisetin with targets of the nuclear factor-\u03baB signal transduction pathway activated by epstein-barr virus encoded latent membrane protein 1","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac. J. Cancer Prevent."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0880","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12885-017-3145-4","article-title":"Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1\/NF-\u03baB\/miR-155\/PU.1 pathway","volume":"17","author":"Wu","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2022.121261_bb0885","first-page":"2935","article-title":"Advances of wogonin, an extract from Scutellaria baicalensis, for the treatment of multiple tumors","volume":"9","author":"Wu","year":"2016","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0890","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2015.03.016","article-title":"Histone deacetylase inhibitor romidepsin induces efficient tumor cell lysis via selective down-regulation of LMP1 and c-myc expression in EBV-positive diffuse large B-cell lymphoma","volume":"364","author":"Shin","year":"2015","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063566","article-title":"Heat shock protein 90 inhibitors repress latent membrane protein 1 (LMP1) expression and proliferation of epstein-barr virus-positive natural killer cell lymphoma","volume":"8","author":"Murata","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.lfs.2022.121261_bb0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134896","article-title":"LMP1 increases expression of NADPH oxidase (NOX) and its regulatory subunit p22 in NP69 nasopharyngeal cells and makes them sensitive to a treatment by a NOX inhibitor","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2022.121261_bb0905","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jphotobiol.2013.07.020","article-title":"FosPeg\u00ae PDT alters the EBV miRNAs and LMP1 protein expression in EBV positive nasopharyngeal carcinoma cells","volume":"127","author":"Wu","year":"2013","journal-title":"J. Photochem. Photobiol. B"},{"issue":"9","key":"10.1016\/j.lfs.2022.121261_bb0910","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/onc.2009.439","article-title":"Epstein-barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b","volume":"29","author":"Anastasiadou","year":"2010","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.lfs.2022.121261_bb0915","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1128\/JVI.02250-07","article-title":"Molecular basis of cytotoxicity of epstein-barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95\/Fas with caspase 8-mediated apoptosis","volume":"82","author":"Le Clorennec","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2022.121261_bb0920","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2147\/CMAR.S159441","article-title":"Blockage of store-operated Ca2+ entry antagonizes epstein-barr virus-promoted angiogenesis by inhibiting Ca2+ signaling-regulated VEGF production in nasopharyngeal carcinoma","volume":"10","author":"Ye","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0925","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.canlet.2015.02.032","article-title":"Blockage of LMP1-modulated store-operated Ca(2+) entry reduces metastatic potential in nasopharyngeal carcinoma cell","volume":"360","author":"Wei","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2022.121261_bb0930","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","article-title":"The PI3K\/AKT pathway as a target for cancer treatment","volume":"67","author":"Mayer","year":"2016","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0935","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5501\/wjv.v1.i6.154","article-title":"Roles of the PI3K\/Akt pathway in epstein-barr virus-induced cancers and therapeutic implications","volume":"1","author":"Chen","year":"2012","journal-title":"World J. Virol."},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0940","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.trecan.2017.04.002","article-title":"Targeting PI3K signaling in combination cancer therapy","volume":"3","author":"Pons-Tostivint","year":"2017","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb0945","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2174\/1389201043376751","article-title":"DNAzymes: from creation in vitro to application in vivo","volume":"5","author":"Achenbach","year":"2004","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"11","key":"10.1016\/j.lfs.2022.121261_bb0950","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024647","article-title":"Down-regulation of EBV-LMP1 radio-sensitizes nasal pharyngeal carcinoma cells via NF-\u03baB regulated ATM expression","volume":"6","author":"Ma","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb0955","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3892\/ijo.2013.2098","article-title":"EBV-LMP1-targeted DNAzyme induces DNA damage and causes cell cycle arrest in LMP1-positive nasopharyngeal carcinoma cells","volume":"43","author":"Ma","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.lfs.2022.121261_bb0960","doi-asserted-by":"crossref","first-page":"S326","DOI":"10.1007\/s12032-010-9681-2","article-title":"EBV-LMP1-targeted DNAzyme restrains nasopharyngeal carcinoma growth in a mouse C666\u20131 xenograft model","volume":"28","author":"Ke","year":"2011","journal-title":"Med. Oncol. (Northwood, London, England)"},{"issue":"8","key":"10.1016\/j.lfs.2022.121261_bb0965","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.18632\/oncotarget.3331","article-title":"EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs\/HIF-1 pathway in nasopharyngeal carcinoma","volume":"6","author":"Yang","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb0970","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4161\/cbt.26606","article-title":"Targeting EBV-LMP1 DNAzyme enhances radiosensitivity of nasopharyngeal carcinoma cells by inhibiting telomerase activity","volume":"15","author":"Yang","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.lfs.2022.121261_bb0975","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114072","article-title":"Conformational change of adenine nucleotide translocase-1 mediates cisplatin resistance induced by EBV-LMP1","volume":"13","author":"Zhao","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0980","first-page":"40","article-title":"The microenvironment in epstein-barr virus-associated malignancies","volume":"7","author":"Tan","year":"2018","journal-title":"Pathogens (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.lfs.2022.121261_bb0985","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAibased therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb0990","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.canlet.2005.02.010","article-title":"siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression","volume":"232","author":"Mei","year":"2006","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.lfs.2022.121261_bb0995","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4161\/cc.6.11.4274","article-title":"Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells","volume":"6","author":"Mei","year":"2007","journal-title":"Cell Cycle"},{"issue":"2","key":"10.1016\/j.lfs.2022.121261_bb1000","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/path.5130","article-title":"Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the epstein-barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma","volume":"246","author":"Lo","year":"2018","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2022.121261_bb1005","article-title":"Cyclophilin a binds to AKT1 and facilitates the tumorigenicity of epstein-barr virus by mediating the activation of AKT\/mTOR\/NF-\u03baB positive feedback loop","volume":"6","author":"Xin","year":"2022","journal-title":"Virol. Sin."},{"issue":"26","key":"10.1016\/j.lfs.2022.121261_bb1010","doi-asserted-by":"crossref","first-page":"11921","DOI":"10.7150\/thno.46006","article-title":"Targeting epstein-barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy","volume":"10","author":"Hu","year":"2020","journal-title":"Theranostics."},{"issue":"23","key":"10.1016\/j.lfs.2022.121261_bb1015","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-\u03b3 up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.lfs.2022.121261_bb1020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/1471-2407-6-283","article-title":"Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immuno- modulatory protein galectin 9","volume":"6","author":"Keryer-Bibens","year":"2006","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2022.121261_bb1025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2022.121261_bb1030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.lfs.2022.121261_bb1040","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/21655979.2019.1694388","article-title":"Construction of epstein-Bar virus cocktail peptide fused with Fc\u03b3 of IgG: as a potential delivery system for vaccine development","volume":"10","author":"Jamehdar","year":"2019","journal-title":"Bioengineered"},{"key":"10.1016\/j.lfs.2022.121261_bb1045","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.2013.51.5304","article-title":"Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins","volume":"32","author":"Bollard","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2022.121261_bb1050","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/s41375-020-1000-0","article-title":"Whole-genome sequencing identifies responders to pembrolizumab in relapse\/refractory natural-killer\/T cell lymphoma","volume":"34","author":"Lim","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.lfs.2022.121261_bb1055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/carcin\/bgs364","article-title":"(-)-Epigallocatechin-3-gallate inhibition of epstein-barr virus spontaneous lytic infection involves ERK1\/2 and PI3-K\/Akt signaling in EBV-positive cells","volume":"34","author":"Liu","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.lfs.2022.121261_bb1060","first-page":"1105","article-title":"(-)-Epigallocatechin-3-gallate inhibition of epstein-barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1","volume":"15","author":"Liu","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.lfs.2022.121261_bb1065","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/jacsau.1c00187","article-title":"Lanthanide-based peptide-directed visible\/near-infrared imaging and inhibition of LMP1Ho","volume":"1","author":"Chau","year":"2021","journal-title":"JACS Au"},{"issue":"5","key":"10.1016\/j.lfs.2022.121261_bb1070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/10428194.2018.1512709","article-title":"The JAK inhibitor antcin H exhibits direct anticancer activity while enhancing chemotherapy against LMP1-expressed lymphoma","volume":"60","author":"Chen","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.lfs.2022.121261_bb1075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.omtn.2019.05.023","article-title":"Targeting exosomal EBV-LMP1 transfer and miR-203 expression via the NF-\u03baB pathway: the therapeutic role of aspirin in NPC","volume":"17","author":"Zuo","year":"2019","journal-title":"Mol. Ther. Nucl. Acids"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522009614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522009614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:04:28Z","timestamp":1758402268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522009614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":213,"alternative-id":["S0024320522009614"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121261","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.121261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121261"}}